Skip to main content
. 2023 Nov 2;15(21):5267. doi: 10.3390/cancers15215267

Table 3.

Performance and cross-validation estimates for the multi-marker model.

AUC Sensitivity Specificity PPV NPV
Cross-Validation 0.981 0.930 0.952 0.950 0.935
Performance on Full Dataset 0.984 0.939 0.953 0.951 0.942
Subtractive Difference % −0.26% −0.85% −0.13% −0.09% −0.64%